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1. ABSTRACT 
 
 
 
Transitional cell carcinoma (TCC) of the bladder is the most frequent 
malignancy of the urinary tract, and its incidence is rising. Depending on the stage of 
the tumor, the treatments for TCC of the bladder may vary from a conservative to a 
radical surgery. In case of invasive TCC of the bladder the gold standard treatment is 
represented by radical cystectomy with extended lymphadenectomy and configuration 
of a continent or non-continent pouch (conduit/pouch/neo-bladder). The reconstructive 
step of radical cystectomy is achieved with the use of bowel segments to restore 
bladder function. Unfortunately, the need for bowel has been universally considered to 
be the prime source of postoperative complications (i.e. fistulas, infections, metabolic 
disorders).  
Since the 1960s urologists, scientists and the industry have been trying to 
obviate t he use of bowel with alternative synthetic and biologic materials to 
reconstruct the bladder. Despite the progress in technology and knowledge, the 
results have been quite discouraging.  Since we are facing a rise in life expectancy 
with increase in both the elderly and bladder cancer population, treatment 
management in these patients represent an important challenge for present and future 
urology. 
In this study we provide an analysis of problems deriving from using bowel for 
urinary bladder diversion, a comprehensive review of literature on pros and cons of 
previous alloplastic and biologic models and a critical analysis of possible benefits 
deriving from restoring urinary bladder function with an ideal synthetic prosthesis. 
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2. INTRODUCTION 
 
 
 
The preservation or restitution of normal function, although not always is 
essential, is certainly the most desiderable goal to be obtained after any surgical 
procedure. In this respect, all operations for total removal of urinary bladder fail. This 
does not imply that the present‘s variety of urinary diversions after radical cystectomy 
(RC) are not satisfactory (for there is much evidence to the contrary), but that these 
operations do not attain the ideal of restoring the normal function of urinary bladder 
and urinary excretion. 
More complex problems have always stimulated the creativity of surgeons. 
Urologist's ―mission‖ to the preservation of the urinary tract, especially of the bladder, 
has guided the search for alternative methods of surgical reconstruction and 
physiological rehabilitation, using the intestine in many sophisticated surgical 
techniques and as the ideal alternative for substitute the urothelium. 
During the last century, since 1851 exactly, urologic surgery has been 
advanced by the development of a great number of new surgical procedures, being 
the removal of urinary bladder and the reconstruction of this part of urinary tract, the 
urological challenge most studied, experimented and debated in literature. Facing the 
problem of a bladder which has lost his function owing to sclerosis of detrusor or in 
case of tuberculosis, or a bladder invaded by a tumor or any other problem which 
could not permit the partial resection of the organ, urologist were historically (and 
are) reduced to perform radical cystectomy always asking themselves with some 
distress ―And now? Where can I place these 2 tubes?‖. 
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A simple question with about twenty different, valid and experimented 
answers. With the only exception of the vascular segment, every kind of intestinal 
segments was used as site of implant of ureters to reconstruct the urinary tract 
including stomach, ileum, cecum, colon, sigma, rectum and direct cutaneous 
diversion without the interpose of bowel [1]. 
Nowadays, the removal of the entire urinary bladder or the augmentation of his 
capacity is obtained exclusively with the use of bowel. While transitional cell 
carcinoma of the bladder represents the most frequent indication to the removal of 
the entire organ, pediatric pathologies and functional ones are the most frequent 
cause for augmentation or total substitution in no-oncological patients. 
TCC of the bladder is the most common malignancy of the urinary tract, with a peak 
incidence in the adult and elderly population [2]. The gold standard treatment for 
muscle-invasive and any non-muscle invasive TCC of the bladder, even in the elderly 
population, is radical cystectomy, [3,4]. Nevertheless, radical cystectomy is a major 
surgical procedure performed with a curative intent and it is accompanied by a high 
rate of complications (17%–66%) [5-7]; its reconstructive part, which counts on 
sampling of bowel to restore urinary bladder function, is generally considered the 
main responsible for postoperative complications, prolonged hospital stay and 
readmission for complication‘s care.  Such complications have an effect on patient‘s 
physical and psychological sphere and increase costs to the National Health system. 
Since we are facing a rise in life expectancy [8] with increase in both the elderly and 
bladder cancer population, treatment management in these patients represent an 
important challenge for present and future urology.  
The function of urinary bladder is to store urine at low pressure and to permit 
voluntary voiding in absence of involuntary leakage of urine so, from a mechanical 
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point of view, it can be considered as a sophisticated waterproof reservoir which fills 
and empties at low pressure [9]. 
Since first cystectomy for bladder tumor, performed in late 1887 by 
Bardenheuer of Cologne, the surgical challenge moved to replace appropriately the 
function of this organ so, progressively, we have seen the developing of surgical 
techniques with reconstruction of the urinary tract aimed to maintain control on 
voluntary voiding and continence, preserve renal function, being aesthetically 
acceptable and providing a good quality of life. 
One of the aspects that have attracted the attention of the industry in the past 
and the present is tissue engineering for organ replacement. The idea of replacing 
bladder with a synthetic scuffle obviating the need for bowel for reconstruction and, 
therefore, ideally diminishing complications during and after radical cystectomy has 
always been attractive and source of investigation.  
Urinary bladder substitutes can be divided into two groups: Biologic and 
Alloplastic. Biologic ones are all urothelial substitutes synthesized or developed from 
living organism, while alloplastic can be simply defined as all non-biological 
materials. 
During these last two decades, progress made in regenerative medicine, cell 
and stem-cell biology, material sciences and tissue engineering, enabled researchers 
to develop cutting-edge technology leading to the ―construction‖ of different tissue 
(10-19). Urology in particular focused his interest in developing a substitute of 
urothelium for both urinary bladder replacement and treatment of urethral stricture. 
On urinary bladder replacement, object of this paper, many were experimenting 
cultures of regenerated multilayer urothelium, being the Group of Atala the first 
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publishing on an ―engineered bladder tissue created with autologous cells usable for 
a cystoplasty‖ [11]. 
While preliminary results on urothelial substitutes and firsts biologic neo-
bladders seems to be promising, drawbacks as cell mutations, biodegradability of the 
scaffold, the lack of direct vascular supply, long-term outcomes of the ―transplanted‖ 
new organ, the still elevated costs together with ethical and oncological 
considerations, were discouraging recommending further steps in this direction [13-
19]. Not least, these promising tissues substitutes of urothelium are unable to carry 
out one of the main function of urinary bladder: that of fill (be distensible) and void 
(be contractile) (Fig.1). 
On the other side, alloplastic materials joined progressively the daily clinical 
practice of every speciality. Urology, in particular, would not be the same without 
devices such as bladder and ureteral catheters. Since the Egyptians first used the 
stalk of papyrus to drain urine thousands of years ago [20], alloplastic materials have 
gradually become more useful, comfortable, and cheaper. However, while in most 
specialties the use of permanent implants is possible (e.g., articular or vascular 
prostheses), in urology this is not feasible yet due to infections and encrustations that 
result from the continual exposure to urine.  
Despite different alloplastic and biologic prosthesis investigated during these 
last 60 years, the aim of replacing this ―simple‖ organ has still not been targeted. 
Technical designs have become more sophisticated and new biomaterials with high 
biocompatibility are now available, but we are still looking for an alternative to bowel 
sampling. 
In this study we provide an analysis of problems deriving from using bowel for 
urinary bladder diversion, a comprehensive review of literature on pros and cons of 
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previous alloplastic and biologic models and a critical analysis of possible benefits 
deriving from restoring urinary bladder function with an ideal synthetic prosthesis. 
 
 
 
 
 
 
 
 
 
 
Figure 1: Construction of engineered bladder (From Reference 11) 
Scaffold seeded with cells (A) and engineered bladder anastamosed to native 
bladder with 4–0 polyglycolic sutures (B); implant covered with fibrin glue and 
omentum (C). 
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3. MATERIAL AND METHODS 
 
 
A comprehensive review of literature was performed using the Medline 
National Library of Medicine database and Google Scholar; key-words used were 
cystectomy and intestine/bowel, replacement, bladder substitution, urinary diversion, 
orthotopic neo-bladder, complications and cystectomy, uretero recto stomy, uretero 
sigma stomy, uretero cutaneous diversion, uretero bowel anastomosis, costs and 
cystectomy, organ replacement, artificial bladder, alloplastic material, biomaterial, 
tissue engineering. We considered suitable for our review all historical models of 
bladder substitute without the use of bowel, emphasizing alloplastic models. The 
review focused on articles between January 1st 1851 and September 1st 2010. Only 
articles in English were considered suitable for the study. 
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4. RESULTS 
 
 
The first attempts of urinary diversion using a uretero-intestinal anastomosis 
were performed in bladder exstrophy. John Simon, in late 1851, was the first that 
suturing both ureters to the rectum caused a spontaneous fistula and subsequent 
uretero-recto-stomy [21]. Lloyd repeated this procedure the same year [22]. Both 
patients died for peritonitis after few days, so the interest in this derivation was 
diluted for many years. 
From an anatomical standpoint three alternatives are presently used after 
cystectomy: 1) Abdominal diversion such us uretero-cutaneo-stomy, ileal or colonic 
conduit and various forms of a continent pouch; 2) Urethral diversion which includes 
various forms of gastrointestinal pouches attached to the urethra as a continent, 
orthotopic urinary diversion (neobladder, orthotopic bladder substitution); 3) Recto-
sigmoid diversions, such as uretero-recto-stomy. 
First‘s urinary bladder substitutions published included direct ureteral 
anastomosis with the bowel without the interruption of his continuity and with 
reconstructions such as uretero-recto or uretero-sigmoid or uretero-colon 
anastomosis, being uretero-sigmoid-stomy, perhaps, the oldest form of urinary 
diversion. It was realized primarily with a refluxive and then with an anti-reflux 
connection of ureters into the bowel [21,23]. Most of the indications for this 
procedure are now obsolete due to a high incidence of upper urinary tract infections 
and the long-term risk of developing colon cancer [24,25]. Bowel frequency and 
urge incontinence were additional side-effects of this type of urinary diversion; 
however, it may be possible to circumvent by interposing a segment of ileum 
between ureters and rectum or sigmoid in order to augment capacity and to avoid a 
4. Results 
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direct interaction between urothelium and colonic mucosa together with faeces and 
urine [26]. The consideration on early and late complications, impose to consider 
different option in uretero-bowel technique opening of a new era in the surgery of 
urinary diversions: that of cutaneous diversion with an isolated segment of bowel. 
The first pioneer cited, Verhoogan M.D., performed in the late 1908, a ―Ureteral 
transplantation into an isolated segment of terminal ileum and ascending colon using 
an appendicostomy as a urethra‖ [27]. All cutaneous diversions counts the 
separation of an isolated segment of bowel from intestinal continuity (with his 
vascular part) in which ureters are anastomized in his lower part while the upper is 
directly anastomized to the skin of the abdominal wall. Progressively, cutaneous 
diversions (non-orthotopic and non-continent) become, and maybe they actually are, 
the standard treatment for Bladder Cancer (BC) in many Centres of the World: a 
―rapid‖ technique with good functional and oncological long-term results.  
The ileal-conduit is still an established option with well-known results however, 
up to 48% of the patients develop early complications including urinary tract 
infections, pyelonephritis, uretero-ileal leakage and stenosis [28]. The main 
complication in log-term follow-up studies are stoma complications in up to 24% of 
patients and functional and/or morphological changes of the upper urinary tract in up 
to 30% of cases [29-31]. An increase in complications was seen with increased 
follow up in one recent serie of 131 patients followed for a minimum of 5 years 
(median follow-up 98 months) [29]: the rate of complications increased from 45% at 
5 years up to 94% in those surviving longer than 15 years. In this group, 50% and 
38% of patients developed upper urinary tract changes and urolithiasis respectively.  
Uretero-cutaneo-stomy is the simplest form of cutaneous diversion and it‘s 
considered as a safe procedure. This surgical technique is preferred in older and 
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compromised patients who need cystectomy and a no longer staying in operating 
room [32,33]. Technically either one ureter to which the other shorter one is 
attached end-to-side is connected to the skin (transuretero-uretero-cutaneo-stomy) or 
both ureters are directly anastomosed to the skin. Due to the small diameter of the 
ureters, stoma stenosis has been observed more often than in intestinal stoma [32]. 
In a recent retrospective comparison with short or median follow-up of 16 months, the 
diversion-related complication rate was considerably lower for uretero-cutaneo-stomy 
compared to an ileal or colon conduit [34]. 
All this until last twenty years when, the psychological problems secondary to 
the distorted body image, to difficulties in having a ‖normal‖ life because of the 
presence of the external urinary-stoma, and the need of the surgeon to propose 
something better functionally and, why not, aesthetically, lead urologists to the last 
step in urinary bladder reconstruction: that of the orthotopic neobladder 
reconstruction. This kind of reconstruction consist in the reconfiguration of an isolated 
segment of bowel (most often the terminal ileum) placed then orthotopically and 
directly anastomosed to ureters and urethra like in native bladder. In several large 
centres, this has become the diversion of choice in most patients undergoing 
cystectomy [35-37]. The empting of the reservoir anastomosed to the urethra 
requires abdominal straining, intestinal peristalsis and sphincter relaxation. Early and 
late morbidity in up to 22% of the patients is reported [38-39]; long-term 
complications include diurnal (8-10%) and nocturnal incontinence (20-30%), uretero-
intestinal stenosis (3-18%), urinary retention (4-12%), metabolic disorders and 
vitamin B12 deficiency in series with 1054 and more than 1,300 patients [36,40]. 
Urethral recurrence in neobladder patients seems rare (1.5-7% for both male and 
female patients) [36,41]. These results indicate that the choice of a neobladder both 
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in male and female patients does not compromise the oncological outcome of 
cystectomy. It remains debatable whether a neobladder is better for quality of life 
compared to a non-continent urinary diversion [42-44]. 
Radical cystectomy (RC) with pelvic lymph node dissection represents the 
most complex and physically demanding (for both patient and surgeon) urological 
surgical procedure, provides the best cancer-specific survival for muscle-invasive 
urothelial cancer [45,46] and is the standard treatment, with 10 years recurrence-
free survival rates of 50-59% and overall survival rates around 45% [45,47]. 
Unfortunately, the need for bowel use has been universally considered to be 
the prime source of postoperative complications with reported early complication (like 
wound infection, prolonged ileus, urinary tract infections, stoma necrosis, necrosis of 
diversion, rectal injury, fascial dehiscense, ureteroileal leakage, intestinal suture 
leakage, pelvic/abdominal abscess, bleeding, fistula, sepsis) rates of 16 % to 61 % ; 
late complications (urinary tract infections, herniation, diarrhea, 
dehidratation/metabolic disorders, uretero-ileal stricture, urethral stricture, fistula, 
stoma stenosis, lymphocele, ileus, vaginal prolapse, severe reflux) rates of 24 % to 
66 % ; metabolic complications (hyperchloremic acidosis; hypochloremic acidosis; 
low vitamine B12, low folic acid); and perioperative mortality of 0.3 to 5.7 % [5-7, 
28, 34, 48-52] (Tab. 1). 
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Table 1: Early postoperative complications reported in large series of radical 
cystectomy (2008–2009). 
 
 
SERIES  
(past decade, around 100 
patients) 
SUMMARY SHABSIGH 
et al, 2009 
NOVARA, 
2009 
BOSTRÖM 
et al, 2009 
MEYER et 
al, 2009 
NIEUWENHU
IJZEN et al, 
2008 
Patients 96-6577 1142 358 258 104 281 
Study period  1995-2005 2002-2006 1986-2005 1994-2003 1990-2005 
Centres  Single SIngle Single Multi (3) Single 
Mortality at 30d 0,3-3,9 1,5 3,0 3,9 1 2,8 
Minor complications 18,6-58 58 36 26 - 19 
Major complications 4,9-25,5 9 13 11 - 24 
One postoperative complications 
ore more 
19-57 64 49 34 24 44 
Operating time, h 4,9-6,4 6,4 5 3,8 5 - 
Estimated blood loss 600-1700 1000 600 1700 1500 - 
Intraoperative transfusion rate (U) 
and perioperative 
1-66 66 15 2,9 2 (in 82%) - 
MEDICAL       
Deep vein thrombosis 0-5,3 5,3 4 1,2 - 1,4 
Pulmonary embolism 0-6 3,2 - 0,8 2 2,5 
Septicaemia 0-9,6 6,6 - 1,2 - 9,6 
Acute respiratory distress 0-3,8 3,5 1 - - 1,1 
Pneumonia 0-7,8 3,9 4 1,9 4 7,8 
Failure to wean from ventilator/on 
ventilator>48h postop 
0-2,6 - - - - - 
Pulm emb; clinical evidence of PE 0-1,9 - - - - - 
Reintubation 0-1,9 - - - - - 
Cardiac (general) 0-13 2,3 4 - - - 
Myocardial infarction 0-4 1,3 1,5 1,9 - 2,1 
Dysrhythmia 0-7,2 7,2 2 1,9 - - 
Cardiac arrest 0-1,3 - - - - - 
Enterocolitis 0-8 3,4 - - - - 
Acute renal failure 0-7 - - - - - 
UTI 0-12,8 9,9 - 5 1 12,8 
Pyelonephritis 0-7,4 2,5 1 3,5 - - 
Metabolic imbalance/delirium 0-4 2 0,3 0,8 - 0,7 
Skin ulcer/pressure sore 0-0,6 0,4 - - - 0,4 
PEG leakage 0-0,4 - - - - 0,4 
Stroke (neurologic) 0-1,4 0,5 0,5 - 1 -- 
SURGICAL        
Periop blood transfusion rate 0-2,3 - - - - - 
Postop haemorrhage; transfusion 
>4U after operation 
0-9 9 - - 1 1,4 
Subileus (paralytic) 0-22,7 16 - 4 - 2,8 
Constipation 0-12 2,6 12 - - - 
GI (emesis, gastritis ulcer) 0-16,1 1,4 3 - - - 
Small bowel obstruction 0-7 7 - 0,8 4 - 
Enteroanastomosis leak 0-8,7 0,9 2 0,4 - 0,7 
Required TotalParentNutrition 0-9 100 - - - - 
GI bleed 0-1,3 1,3 - - - - 
Pyrexia of unknow origin 0-7,0 4,8 7 - - - 
Pelvic lymphocoele with 
intervention 
0-3,5 1,3     
Pelvic lymphocele (no intervent.) 0-5,4 - - - - - 
Precutaneous draiange 0.2,7 - - - - - 
Peritonitis 0-0,8      
Wound infection, including superf. 0-15 9,3 - 0,8 4 8 
Deep (fascial/muscle) inf       
Wound dehiscense 0-9 4,6 5 - 3 5 
Secondary healing 0-8 - 3 - - - 
With revision 0-5 - 2 - - - 
Pelvic haematoma 0-2 - 1 - - - 
Pelvic/abd abscess 0-4,4 4,4 - - - 1,1 
Without revision 0-0,4 0,4 - - - - 
With revision 0-0,4 - - - - - 
Diversion related 0-16 - - - - - 
Urine leak/pouch leak/other 0-7,7 2,6 1 - 3 - 
Stomal necrosis/structure 0-1,7 0,4 - - - 0,7 
Diversion necrosis 0-0,7 - - - - 0,7 
Rectal injury 0-1,7 - - - - 0,7 
Fistula 0-4 - 0,5 - - 0,4 
Reoperation rate 0-17 3 10 8 8 - 
Other 0-14,5 4 8,3 5 1 - 
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Since the 1960s urologists, scientists and the industry have been trying to 
obviate the use of bowel with alternative synthetic materials to reconstruct the 
bladder. Despite the progress in technology and knowledge, the results have been 
full quite discouraging.  
Various prostheses have been proposed for replacement of the urinary 
bladder being silicone the most widely used material: a plastic reservoir and 
mechanical valves with abdominal drainage of urine via a silicone tube; silicone 
rubber prosthesis with transurethral drainage of urine; a bistable latex prosthesis; a 
silicone rubber reservoir and an artificial urethra equipped with a sphincter.  
A variety of other prostheses which may entail the use of Gore-tex, may or 
may not be orthotopic, and range from the simple to the sophisticated and from the 
rigid to the distensible. The most successful of the prostheses is that described by 
Rohrmann et al. and the last one derives from 1996, from the Mayo Clinic.  
Here we report one of the representative models of alloplastic bladder 
published during this last 60 years. 
Bogash model [53]: in this first model of artificial bladder, presented in late 
1960 by the pioneer in alloplastic substitution of the urinary bladder (M. Bogash), 
ureters drained into a silicone tube connected to the external abdominal wall. Cons: 
Hydroureteronephrosis due to retractile scarring in ureteral anastomosis sites and 
urinary infection secondary to the external connection ensued, and none of the 
devices survived for more than 4 weeks.  
One of the most sophisticated models was that known as the Mayo Clinic 
model  presented by O‘Sullivan et al [54] (Fig. 2): the model was based on negative 
pressure drainage of urine from kidneys and active voiding. It consisted of two 
different shells: an inner one of silicone (230 ml) surrounded by an external one of 
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polysulfane (300 ml). Both were connected to the bladder neck with a 70-ml space 
between them. An internal spring mechanism generated negative pressure when 
compressed, facilitating filling, and a similar pressurized mechanism facilitated 
voiding. Ureters were intubated with an 8-Fr silicone catheter reinforced with a nylon 
spiral and the prosthesis drained under positive pressure into a silicon tube inserted 
into the urethra. Watertight anastomosis was ensured by Dacron reinforcement in 
anastomosis sites. Cons: this too complex model failed inexorably within a few weeks 
because of infections and technical failure of components. 
Another complex device, but with the longest known life (more than 18 months 
in two animals with no technical problems), was that known as the Aachen model 
described by Rohrmann et al [55]. It consisted of two separated subcutaneous and 
compressible elastic reservoirs which drained urine from each kidney via a Dacron-
covered silicone tube placed through the renal parenchyma like an ―artificial ureter‖. 
Both reservoirs drained into the urethra through the interposition of a silicone tube 
with a ―Y‖ form; external compression caused the positive pressure useful for voiding, 
with contemporaneous negative pressure within the reservoir to increase filling.  
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Figure 2: Anterior and lateral aspect of the Mayo clinic model (From reference 54) 
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5. DISCUSSION 
 
 
As highlighted by the above results, many have already attempted to discover 
the ideal alloplastic neo-bladder however this result has yet to come. The main 
causes of failure of all these models were: deposition of connective tissue, 
encrustations, infections, hydroureteronephrosis, leakage of urine from urethral or 
ureteral anastomosis, and problems related to biocompatibility being silicone the 
most widely used material. Despite its biocompatibility, flexibility, and durability, it has 
been shown that silicone is not the ideal material for bladder substitution because of 
its low resistance to infection and encrustation. A critical and careful analysis of all 
the causes of failure might permit extrapolation of fundamental data and 
development of guidelines for future models as listed by Desgrandchamps [56]. It is 
possible that scientific collaboration between engineers, biologists, and 
biomaterialists, with incorporation of recent developments and know-how in tissue 
engineering, would lead to technical and practical remedies to previous problems, 
and identification of all the features required for the ideal alloplastic bladder. 
Ideally, a well-functioning reservoir for urine would be totally biocompatible and 
impermeable, store a sufficient volume of urine, permit filling and voluntary voiding 
without any pressure repercussions in the upper urinary tract, avoid any leakage of 
urine, resist encrustation and infection, be simple to implant and simple to replace in 
case of malfunction, and have an acceptable duration.  
A new alloplastic reservoir that meets these requirements could have 
enormous clinical/practical, physical, psychological, and economic benefits. The 
need to restore bowel function is the principal reason why duration of surgery and 
inpatient recovery time are lengthy. Without the need for bowel surgery, the operation 
would entail simple reimplantation of ureters and urethra, easily halving the duration 
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of surgery and the recovery time. Indirectly this would permit a reduction in drug 
administration during surgery and hospitalization, thereby saving money. The 
resultant quicker turnover of patients would also permit a reduction in the waiting list 
for surgery. Furthermore, absence of use of bowel segments to restore bladder 
function would potentially reduce readmission for potential attendant complications. 
In psychological terms, orthotopic prosthesis would also have evident benefits 
respect to external stoma [57-60]. Avoiding bowel surgery physical activities would 
be more rapidly restored, with faster progression to adjuvant therapies on account of 
a better physical condition. The lack of need for bowel surgery would reduce too the 
enormous economic cost incurred by every National Health System owing to use of 
the instruments needed for bowel surgery (mechanical stapler, suture needles, etc.), 
use of devices such as external stoma appliances/bags (for patients with external 
stoma) or of pads (in incontinent patients with orthotopic reconstruction), and the 
need for subsequent interventions or readmission to the hospital. Secondary, the 
identification of a biomaterial which can be used as a surrogate for urothelium could 
be of value in the majority of the pediatric pathologies which require the use of bowel 
(e.g., neurogenic bladder, bladder exstrophy). Finally, the identification of such 
biomaterial resistant to infection, encrustation and with an acceptable duration in 
contact with urine, may provide a new ―family‖ of urological devices.  
The question remains as to whether and how a biomaterial with the above 
described properties will become available for commercial and medical use since up 
to now none is available. 
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6. CONCLUSIONS 
 
 
The pool of patients affected by bladder cancer is increasing also because of 
the rise in life expectancy. Radical cystectomy is the gold standard treatment for 
muscle-invasive bladder cancer and bowel sampling for bladder substitution is still 
the only reconstructive alternative for such patients. Although artificial or biologic 
substitution of the bladder would be desirable due to the physical, psychological, 
technical, and economic benefits, an alloplastic or biologic material with compatible 
properties to the human body has yet to be discovered. So, the answer to the 
question proposed in the title (―is there a place for bowel in the future?‖) must be 
unequivocal ―no‖, but not actually! Indeed, the repeated failure of this therapeutic 
approach has been one of the factors prompting researchers to explore tissue 
engineering and other alternatives to conventional enterocystoplasty. Inter-
professional collaboration, recent advances in technology, and innovations in tissue 
engineering may help in developing suitable alloplastic prosthesis. Therefore both 
urologists, as well as engineers and the industry need to give this matter a serious 
attention. 
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